Evidence map›Paper›PMID 37905225›Full record

ArticleMagnetic resonance (Gottingen, Germany)2021

NUScon: a community-driven platform for quantitative evaluation of nonuniform sampling in NMR.

Yulia Pustovalova, Frank Delaglio, D Levi Craft, Haribabu Arthanari, Ad Bax, Martin Billeter, Mark J Bostock, Hesam Dashti, D Flemming Hansen, Sven G Hyberts and 18 more

Abstract read
In one paragraph

Article in Magnetic resonance (Gottingen, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Evaluating metrics of spectral quality in nonuniform sampling.Journal of magnetic resonance open · 2025
    Article
  5. Article
  6. Article
  7. Exploring Sulfur Sites in Proteins via Triple-ResonanceJournal of the American Chemical Society · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Yulia PustovalovaDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA.
Frank DelaglioInstitute for Bioscience and Biotechnology Research, National Institute of Standards and Technology and the University of Maryland, Rockville, MD 20850, USA.
D Levi CraftDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA.
Haribabu ArthanariDepartment of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA.
Ad BaxLaboratory of Chemical Physics, NIDDK, National Institutes of Health, Bethesda, MD 20892, USA.
Martin BilleterDepartment of Chemistry and Molecular Biology, University of Gothenburg, Box 465, Gothenburg 405 30, Sweden.
Mark J BostockDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK.
Hesam DashtiDivision of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.
D Flemming HansenDepartment of Structural and Molecular Biology, Division of Biosciences, University College London, London WC1E 6BT, UK.
Sven G HybertsDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Bruce A JohnsonStructural Biology Initiative, CUNY Advanced Science Research Center, New York, NY 10031, USA.
Krzysztof KazimierczukCentre of New Technologies, University of Warsaw, 02-097 Warsaw, Poland.
Hengfa LuDepartment of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China.
Mark MaciejewskiDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA.
Tomas M MiljenovićCentre for Advanced Imaging, The University of Queensland, 4072 St Lucia, Queensland, Australia.
Mehdi MobliCentre for Advanced Imaging, The University of Queensland, 4072 St Lucia, Queensland, Australia.
Daniel NietlispachDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK.
Vladislav OrekhovDepartment of Chemistry and Molecular Biology, University of Gothenburg, Box 465, Gothenburg 405 30, Sweden.
Robert PowersDepartment of Chemistry and Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln, Lincoln, NE 68588-0304, USA.
Xiaobo QuDepartment of Electronic Science, Biomedical Intelligent Cloud R&D Center, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen 361005, China.
Scott Anthony RobsonDepartment of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN 47405, USA.
David RovnyakDepartment of Chemistry, Bucknell University, Lewisburg, PA 17837, USA.
Gerhard WagnerDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Jinfa YingLaboratory of Chemical Physics, NIDDK, National Institutes of Health, Bethesda, MD 20892, USA.
Matthew ZambrelloDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA.
Jeffrey C HochDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA.
David L DonohoDepartment of Statistics, Stanford University, Stanford, CA 94305, USA.
Adam D SchuylerDepartment of Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA.

Funding

Targeted mass spectrometry approaches to understand CART processing and recepter interactionsP20GM113126 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI RAZAVI RIZI, MOHAMMAD · 2016 to 2025
$20.8M
TRD3 NMRbox: Bayesian AnalyticsP41GM111135 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HOCH, JEFFREY C · 2015 to 2024
$14.0M
NIGMS NIH HHS P20 GM113126NIGMS NIH HHS P41 GM111135
6 · The paper itself

Abstract

Although the concepts of nonuniform sampling (NUS​​​​​​​) and non-Fourier spectral reconstruction in multidimensional NMR began to emerge 4 decades ago , it is only relatively recently that NUS has become more commonplace. Advantages of NUS include the ability to tailor experiments to reduce data collection time and to improve spectral quality, whether through detection of closely spaced peaks (i.e., "resolution") or peaks of weak intensity (i.e., "sensitivity"). Wider adoption of these methods is the result of improvements in computational performance, a growing abundance and flexibility of software, support from NMR spectrometer vendors, and the increased data sampling demands imposed by higher magnetic fields. However, the identification of best practices still remains a significant and unmet challenge. Unlike the discrete Fourier transform, non-Fourier methods used to reconstruct spectra from NUS data are nonlinear, depend on the complexity and nature of the signals, and lack quantitative or formal theory describing their performance. Seemingly subtle algorithmic differences may lead to significant variabilities in spectral qualities and artifacts. A community-based critical assessment of NUS challenge problems has been initiated, called the "Nonuniform Sampling Contest" (NUScon), with the objective of determining best practices for processing and analyzing NUS experiments. We address this objective by constructing challenges from NMR experiments that we inject with synthetic signals, and we process these challenges using workflows submitted by the community. In the initial rounds of NUScon our aim is to establish objective criteria for evaluating the quality of spectral reconstructions. We present here a software package for performing the quantitative analyses, and we present the results from the first two rounds of NUScon. We discuss the challenges that remain and present a roadmap for continued community-driven development with the ultimate aim of providing best practices in this rapidly evolving field. The NUScon software package and all data from evaluating the challenge problems are hosted on the NMRbox platform.

Identifiers

PMID37905225
PMCPMC10583271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.